Q4 2024 Earnings Conference Call February 14, 2025 3:00 AM ETCompany ParticipantsMasamichi Terabatake - Group President ...

Ferring Pharmaceuticals announced today three abstracts featuring ADSTILADRIN® (nadofaragene firadenovec-vncg) will be presented at the 2025 American Society of Clinical Oncologists Genitourinary ...

Just a few months after Vir Biotechnology lost an emergency authorization for its COVID-19 antibody, Marianne de Backer ...

The FDA approved betibeglogene autotemcel (beti-cel; Zynteglo) for adult and pediatric patients with transfusion-dependent ...

Using “cure” to refer to “obtaining a normal life” also fits — if you ignore previously lost education, career opportunities ...

CSL Behring's gene therapy Hemgenix four years post-infusion data continue to show sustained efficacy and safety in adults with haemophilia B: King of Prussia, Pennsylvania Monday ...

Forever chemicals "can disrupt hormones in your body and lead to problems, things like increased risk of breast cancer, problems with fertility." ...

In summary, enalapril significantly mitigated multiple pathological markers associated with aging, including lipid droplets, amyloid, glycogen deposition, and fibrosis, in the brain, kidneys, liver, ...

SANTA CLARA, Calif. - HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company with a current market capitalization of ...

Robin Fields ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as ...

This story was originally published in The Highlight, Vox’s member-exclusive magazine. To get early access to ...